BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37232801)

  • 1. Immunotherapy in Anal Cancer.
    Dhawan N; Afzal MZ; Amin M
    Curr Oncol; 2023 Apr; 30(5):4538-4550. PubMed ID: 37232801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape.
    Lum C; Prenen H; Body A; Lam M; Segelov E
    Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):665-680. PubMed ID: 32458709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.
    Martin D; Rödel F; Balermpas P; Rödel C; Fokas E
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):221-230. PubMed ID: 28501560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in Anal Cancer.
    Phuong L; Rajdev L
    Curr Oncol Rep; 2020 Jul; 22(9):94. PubMed ID: 32651760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal Cancer: The Past, Present and Future.
    Gondal TA; Chaudhary N; Bajwa H; Rauf A; Le D; Ahmed S
    Curr Oncol; 2023 Mar; 30(3):3232-3250. PubMed ID: 36975459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
    Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of Anal Cancer.
    Hoff PM; Coudry R; Moniz CM
    Surg Oncol Clin N Am; 2017 Jan; 26(1):57-71. PubMed ID: 27889037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Eng C
    J Natl Compr Canc Netw; 2018 Jul; 16(7):903-908. PubMed ID: 30006430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the management of anal cancer.
    Symer MM; Yeo HL
    F1000Res; 2018; 7():. PubMed ID: 30345012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Squamous cell anal carcinoma. What's next ?].
    Kim S; Spehner L; Cabel L; Bidard FC; Borg C
    Bull Cancer; 2021 Jan; 108(1):80-89. PubMed ID: 33423780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anal squamous cell carcinoma - State of the art management and future perspectives.
    Martin D; Balermpas P; Winkelmann R; Rödel F; Rödel C; Fokas E
    Cancer Treat Rev; 2018 Apr; 65():11-21. PubMed ID: 29494827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anal cancer treatment: current status and future perspectives.
    Ghosn M; Kourie HR; Abdayem P; Antoun J; Nasr D
    World J Gastroenterol; 2015 Feb; 21(8):2294-302. PubMed ID: 25741135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the treatment of anal cancer: an overview of the latest investigational drugs.
    Yu J; Kim RD
    Expert Opin Investig Drugs; 2024 Feb; 33(2):145-157. PubMed ID: 38275174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management of squamous cell carcinoma of the anal canal: where are we now?
    Eng C; Ahmed S
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):877-86. PubMed ID: 24981728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and Predictive Markers for Patients With Anal Cancer.
    Holliday EB; Peddireddy A; Morris VK
    J Natl Compr Canc Netw; 2023 Jun; 21(6):678-684. PubMed ID: 37308122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy.
    Yanik EL; Kaunitz GJ; Cottrell TR; Succaria F; McMiller TL; Ascierto ML; Esandrio J; Xu H; Ogurtsova A; Cornish T; Lipson EJ; Topalian SL; Engels EA; Taube JM
    JAMA Oncol; 2017 Jul; 3(7):974-978. PubMed ID: 28334399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational drugs for treating anal cancer and future perspectives.
    Bustamante L; Frakes J; Hoffe S; Kim R
    Expert Opin Investig Drugs; 2016; 25(1):51-62. PubMed ID: 26560877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of Autophagy Contributes to Anal Carcinogenesis.
    Carchman EH; Matkowskyj KA; Meske L; Lambert PF
    PLoS One; 2016; 11(10):e0164273. PubMed ID: 27706233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic Anal Cancer and Novel Agents.
    Morris V; Eng C
    Surg Oncol Clin N Am; 2017 Jan; 26(1):133-142. PubMed ID: 27889032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.